Morgan Stanley (MS)
Mexican Exchange · Mexico · prices in MXN · close of 21 Oct 2026
Key indicators
| Last close | MXN 3,457.00 |
|---|---|
| 52-week range | 2,750.00 – 3,977.00 |
| Return, 1 month / 3 months | −1.6% / −7.8% |
| Return, 1 year / 3 years | +19.9% / +182.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 50 |
| Volatility (1 year) | 25.7% |
| Worst drawdown (1 year) | -17.4% |
| Average daily value traded | 2.38M MXN |
| Dividend yield | 2.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Morgan Stanley is a financial services firm based in New York that serves corporations, institutions and individual investors. It provides investment banking advice on mergers, acquisitions and raising capital, along with sales and trading of securities. Its wealth management arm offers brokerage, financial planning and advisory services to retail clients, while its investment management business runs funds and portfolios for institutional and individual customers around the world.
The shares are listed on the Mexican Exchange in Mexico under the code MS, and the price on this page is in Mexican pesos (MXN). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Morgan Stanley (MS) trades on the Mexican Exchange in Mexico. It last closed at MXN 3,457.00 on 21 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 149 of 361 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 19.9% and over the last three months it fell 7.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Mexican Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.2% | ||
| From 52-week high | -13.1% | ||
| Momentum | 50 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -7.8% | ||
| 6-month return | 7.8% | ||
| 12-month return, skipping the last month | 21.9% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 25.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.4% | ||
| Liquidity | 46 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 2.38M MXN | ||
| Zero-volume days | 38.3% | ||
| Income | 62 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.1% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +4.1% |
|---|---|
| 1 month | −1.6% |
| 3 months | −7.8% |
| 6 months | +7.8% |
| 1 year | +19.9% |
| 3 years | +182.9% |
| 5 years | +106.1% |
Signals
| 50-day / 200-day average | 3,548.87 / 3,383.10 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 50.03 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 31 Jul 2026 | MXN 19.9530 |
| 30 Apr 2026 | MXN 17.5120 |
| 30 Jan 2026 | MXN 17.3470 |
| 31 Oct 2025 | MXN 18.5515 |
| 31 Jul 2025 | MXN 18.8285 |
| 30 Apr 2025 | MXN 18.1069 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Mexican Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.